Makindo Medical Notes"One small step for man, one large step for Makindo" |
|
|---|---|
| Download all this content in the Apps now Android App and Apple iPhone/Pad App | |
| MEDICAL DISCLAIMER: The contents are under continuing development and improvements and despite all efforts may contain errors of omission or fact. This is not to be used for the assessment, diagnosis, or management of patients. It should not be regarded as medical advice by healthcare workers or laypeople. It is for educational purposes only. Please adhere to your local protocols. Use the BNF for drug information. If you are unwell please seek urgent healthcare advice. If you do not accept this then please do not use the website. Makindo Ltd. |
Related Subjects: |Colorectal cancer |Colorectal polyps |Ulcerative Colitis |Acute Severe Colitis |Crohn's disease
🌟 Anti-TNF agents (e.g., infliximab, adalimumab) have revolutionised Crohn’s disease care, improving remission rates and quality of life. They are particularly important for severe or fistulating disease.
| Feature | 🌱 Crohn’s Disease | 🔥 Ulcerative Colitis |
|---|---|---|
| Distribution | Anywhere mouth → anus, most often terminal ileum; skip lesions | Starts in rectum, continuous spread proximally through colon |
| Depth of Inflammation | Transmural (full thickness) | Mucosa + submucosa only |
| Histology | Non-caseating granulomas, fissures | Crypt abscesses, mucosal ulceration, no granulomas |
| Appearance | “Cobblestone” mucosa, thick bowel wall, strictures, fistulas | Red, raw, friable mucosa, pseudopolyps |
| Symptoms | RLQ pain, weight loss, diarrhoea (± blood), perianal disease | Bloody diarrhoea, urgency, tenesmus, LLQ pain |
| Smoking | 🚬 Risk factor (worsens disease) | 🚭 Protective (symptoms often worse in ex-smokers) |
| Extra-intestinal | More renal stones (oxalate), gallstones, B12 deficiency | PSC (primary sclerosing cholangitis), ↑ colorectal cancer risk |
| Fistula/Stricture | ✅ Common (entero-enteric, perianal, entero-vesical) | ❌ Rare |
| Surgery | Not curative (recurs in new bowel segments) | Curative (colectomy removes disease) |
| Cancer risk | Increased with colonic involvement | High with long-standing pancolitis or PSC |
💡 Teaching Tip: In exams, remember the mnemonic:
| Step | Therapy |
|---|---|
| 1 | 5-ASA (Sulfasalazine, Mesalazine, Olsalazine) – colitis pattern |
| 2 | Oral Budesonide – ileal disease |
| 3 | Oral Prednisolone (40–60 mg, taper) |
| 4 | IV steroids (Hydrocortisone/Methylprednisolone) |
| 5 | Azathioprine / 6-Mercaptopurine |
| 6 | Methotrexate (weekly) |
| 7 | Anti-TNF (Infliximab, Adalimumab) |
| 8 | IV Ciclosporin / Tacrolimus (selected refractory cases) |
Crohn’s disease is a chronic, relapsing transmural granulomatous inflammation that can affect any part of the GI tract, classically with “skip lesions.” Presentations vary: • Ileal disease → pain, diarrhoea, weight loss, anaemia. • Perianal disease → fistulae, abscesses, often severe. • Stricturing disease → obstruction from chronic inflammation and fibrosis. Management depends on severity and phenotype: steroids for induction, immunomodulators/biologics for maintenance, and surgery for complications. Unlike ulcerative colitis, Crohn’s often recurs after surgery. Long-term care must also address nutrition, bone health, and cancer surveillance.